CompletedNot Applicable

DYG Versus Cetrorelix in Oocyte Donation

202 participantsStarted 2017-01-01

Plain-language summary

Prospective controlled study to assess the reproductive outcomes of OD recipients in which the donors were subjected to the DYG protocol (20mg/day) compared with those subjected to the short protocol with cetrorelix (0.25 mg/day) from Day 7 or since a leading follicle reached 14 mm. The OD cycles were triggered with triptoreline acetate and the trigger criterion was ≥3 follicles of diameter \>18mm.

Who can participate

Age range21 Years – 30 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Oocyte donors between 21 and 30 years old, with regular menstrual cycles (24-35 d) and a body mass index (BMI) between 18 and 28 kg/m2 without any relevant personal or family history Exclusion Criteria: * AMH less than 3 ng/dL * A positive screening for sexually transmitted diseases

What they're measuring

Live Birth Rate per transfer

Timeframe: 40 weeks after ET

Clinical pregnancy per transfer

Timeframe: 12 weeks after ET

Miscarriage rate

Timeframe: 12 weeks after ET

Trial details

NCT IDNCT05577806

SponsorClinica de la Mujer Medicina Reproductiva, Chile

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Infertility, Female trials